TheraBrake Inc.

Therapeutics utilizing access via the “brake” technology and treatment through the gut, Therabrake is aiming to treat Alzheimer’s disease as a metabolic disease progression.

  • Technology Presenter: Jerome J Schentag, Founder and CEO
  • Accelerator-Commercial Catalyst:Caroline Hoedemaker
  • Defined Milestone: Examine Alzheimer’s as a separately treatable disease from the “Brake” technology
  • Targeted Completion: 1 month